10mM L- methionine
Sponsors
Rezolute Inc.
Conditions
Hypoglycemia associated with congenital hyperinsulinismTumor-associated hyperinsulinism
Phase 3
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Study to Evaluate the Efficacy and Safety of RZ358 in Patients with Congenital Hyperinsulinism
Active, not recruitingCTIS2023-503240-13-00
Start: 2024-01-30Target: 32Updated: 2025-11-11
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ersodetug in Patients with Inadequately Controlled Hypoglycemia Due to Tumor-Associated Hyperinsulinism (tumorHI)
Not yet recruitingCTIS2024-515447-36-00
Target: 12Updated: 2025-07-22